Hideo Takasu

681 total citations
15 papers, 571 citations indexed

About

Hideo Takasu is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hideo Takasu has authored 15 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hideo Takasu's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (4 papers) and vaccines and immunoinformatics approaches (3 papers). Hideo Takasu is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (4 papers) and vaccines and immunoinformatics approaches (3 papers). Hideo Takasu collaborates with scholars based in Japan and United States. Hideo Takasu's co-authors include Hideaki Yamana, Shigeki Shichijo, Damu Yang, Kyogo Itoh, Yasuhisa Imai, Masanobu Nakao, Fumihiko Niiya, Yuji Toh, Kenji Harada and Kazuo Shirouzu and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Clinical Cancer Research.

In The Last Decade

Hideo Takasu

15 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideo Takasu Japan	10	360	320	226	70	40	15	571
Ilaria Cattarossi Italy	11	336 0.9×	309 1.0×	154 0.7×	44 0.6×	45 1.1×	14	569
Jürgen C. Becker Germany	8	594 1.6×	317 1.0×	384 1.7×	57 0.8×	49 1.2×	8	766
Long V. Ly Netherlands	14	393 1.1×	244 0.8×	250 1.1×	57 0.8×	114 2.9×	19	753
Jani Huuhtanen Finland	11	335 0.9×	250 0.8×	268 1.2×	68 1.0×	38 0.9×	25	595
Annamaria De Filippo Italy	8	445 1.2×	249 0.8×	395 1.7×	24 0.3×	25 0.6×	9	685
Claire Mazumdar United States	4	316 0.9×	241 0.8×	289 1.3×	90 1.3×	14 0.3×	4	585
Tom J. Harryvan Netherlands	10	340 0.9×	242 0.8×	449 2.0×	101 1.4×	31 0.8×	15	642
Nancy J. Crowley United States	10	260 0.7×	190 0.6×	374 1.7×	45 0.6×	30 0.8×	15	556
Inge H. G. Bronkhorst Netherlands	13	438 1.2×	262 0.8×	244 1.1×	56 0.8×	119 3.0×	17	838
Paula A. Clark United Kingdom	13	315 0.9×	294 0.9×	260 1.2×	73 1.0×	9 0.2×	18	667

Countries citing papers authored by Hideo Takasu

Since Specialization

Citations

This map shows the geographic impact of Hideo Takasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideo Takasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideo Takasu more than expected).

Fields of papers citing papers by Hideo Takasu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideo Takasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideo Takasu. The network helps show where Hideo Takasu may publish in the future.

Co-authorship network of co-authors of Hideo Takasu

This figure shows the co-authorship network connecting the top 25 collaborators of Hideo Takasu. A scholar is included among the top collaborators of Hideo Takasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideo Takasu. Hideo Takasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Goto, Masashi, et al.. (2016). DSP-7888, a Novel Cocktail Design of WT1 Peptide Vaccine, and Its Combinational Immunotherapy with Immune Checkpoint-Blocking Antibody Against PD-1. Blood. 128(22). 4715–4715. 5 indexed citations

Hida, Yasuhiro, Noritaka Ohga, Hideshi Sato, et al.. (2014). Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells. Cancer Science. 105(5). 560–567. 25 indexed citations

Hirohashi, Yoshihiko, Toshihiko Torigoe, Terufumi Kubo, et al.. (2013). Expression and function of FERMT genes in colon carcinoma cells.. Anticancer Research. 33(1). 167–73. 12 indexed citations

Nakatsugawa, Munehide, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2009). Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4. Cancer Science. 100(8). 1485–1493. 31 indexed citations

Inoda, Satoko, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2009). Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma. Journal of Immunotherapy. 32(5). 474–485. 81 indexed citations

Sato, Eiji, Toshihiko Torigoe, Yoshihiko Hirohashi, et al.. (2008). Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma. Clinical Cancer Research. 14(21). 6916–6923. 29 indexed citations

Sato, Yuriko, Hiroeki Sahara, Tomohide Tsukahara, et al.. (2002). Improved generation of HLA class I/peptide tetramers. Journal of Immunological Methods. 271(1-2). 177–184. 15 indexed citations

Gotoh, Masashi, Hideo Takasu, Kenji Harada, & Takashi Yamaoka. (2002). Development of HLA‐A2402/K^b transgenic mice. International Journal of Cancer. 100(5). 565–570. 21 indexed citations

Takasu, Hideo. (2001). Interferon-.ALPHA.: An Effective Adjuvant for Peptide-Based Cytotoxic T-cell Vaccines.. The Kurume Medical Journal. 48(2). 171–174. 5 indexed citations

10.

Harada, Kenji, et al.. (2000). Mouse Homologue of the Human SART3 Gene Encoding Tumor‐rejection Antigen. Japanese Journal of Cancer Research. 91(2). 239–247. 9 indexed citations

11.

Yang, Damu, Motoki Nakao, Shigeki Shichijo, et al.. (1999). Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.. PubMed. 59(16). 4056–63. 138 indexed citations

12.

Shichijo, Shigeki, Masanobu Nakao, Yasuhisa Imai, et al.. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. The Journal of Experimental Medicine. 187(3). 277–288. 184 indexed citations

13.

Gotoh, Masashi, Shigeki Shichijo, Tomoaki Hoshino, et al.. (1998). Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor‐rejection Antigen SART‐1. Japanese Journal of Cancer Research. 89(8). 849–854. 3 indexed citations

14.

Toh, Uhi, Hideaki Yamana, Masanobu Nakao, et al.. (1997). HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers. Cellular Immunology. 177(2). 137–143. 10 indexed citations

15.

Morozumi, Makoto, et al.. (1993). PRIMARY NON-HODGKIN LYMPHOMA OF THE PROSTATE: A Case Report. The Japanese Journal of Urology. 84(11). 2023–2026. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact